Patents by Inventor Marie-Clotilde Rissoan

Marie-Clotilde Rissoan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INDUCTION OF APOPTOSIS IN TOLL-LIKE RECEPTOR EXPRESSING TUMOR CELLS
    Publication number: 20090285779
    Abstract: Some types of cancer cells express one or more Toll-like receptors (TLRs). These TLRs are therapeutic targets. The invention relates to methods for treating Toll-like receptor expressing cancers and tumor cells by selecting a TLR expressing tumor cell and contacting the cell with a therapeutically effective amount of a TLR ligand. The invention particularly relates to methods for treating TLR3 expressing cancers and tumor cells using TLR3 agonists.
    Type: Application
    Filed: December 6, 2007
    Publication date: November 19, 2009
    Inventors: SERGE LEBECQUE, Toufic Renno, Bruno Salaun, Isabelle Coste-Invernizzi, Marie-Clotilde Rissoan
  • Induction of apoptosis in toll-like receptor expressing tumor cells
    Publication number: 20060147456
    Abstract: Some types of cancer cells express one or more Toll-like receptors (TLRs). These TLRs are therapeutic targets. The invention relates to methods for treating Toll-like receptor expressing cancers and tumor cells by selecting a TLR expressing tumor cell and contacting the cell with a therapeutically effective amount of a TLR ligand. The invention particularly relates to methods for treating TLR3 expressing cancers and tumor cells using TLR3 agonists.
    Type: Application
    Filed: July 19, 2005
    Publication date: July 6, 2006
    Inventors: Serge Lebecque, Toufic Renno, Bruno Salaun, Isabelle Coste-Invernizzi, Marie-Clotilde Rissoan
  • Dendritic cell-derived nucleic acids and related compositions and methods
    Publication number: 20050118575
    Abstract: Genes related to dendritic cells of the immune system have been isolated, cloned, sequenced, and functionally identified. These nucleic acids and encoded proteins can be used for diagnostic and therapeutic purposes.
    Type: Application
    Filed: July 17, 2001
    Publication date: June 2, 2005
    Inventors: Marie-Clotilde Rissoan, Jean-Michel Bridon, Thomas Duhen, Francine Briere, Elizabeth Bates